{"task_id": "396d13395c97693e", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 143/464)", "text": "hepatic\nSPECIFIC ENTITIES (CONT\u2019D)\n130\nHepatitis B\n\n--- Page 152 ---\nDIAGNOSTIC ISSUES (CONT\u2019D)\ninjury. HBeAg negative infection is associated with\nfluctuating ALT and lower levels of HBV DNA. By\ndefinition, HBeAg seroconversion cannot occur\n\u0002 HBEAB\nantibody against hepatitis B envelope\nprotein. Suggests low/no viral replication, usually\nwith low infectivity\nDIAGNOSTIC ISSUES (CONT\u2019D)\n\u0002 HBV DNA\ndirect determination of hepatitis B\nvirus DNA. HBV DNA level reflects viral replication\nactivity and is associated with the risk of cirrhosis\nand hepatoma. HBV DNA determination is impor\ntant in both HBeAg+ and HBeAg\nindividuals to\ndetermine need for antiviral therapy\nMANAGEMENT\nLIFESTYLE CHANGES\navoid alcohol use, sexual\neducation, HBV vaccination\nTREAT UNDERLYING CAUSE\ninterferon, pegylated\ninterferon, lamivudine, adefovir, entecavir, telbivu\ndine, tenofovir\nVACCINATION\nhousehold and sexual contacts\nTREATMENT ISSUES\nTREATMENT DECISION FOR CHRONIC HEPATITIS B\nINFECTIONS\n\u0002 HBEAG POSITIVE PATIENTS\nno spontaneous sero\nconversion after 6 months with recurrent flares,\nTREATMENT ISSUES (CONT\u2019D)\nsignificant fibrosis or inflammation, or polyarteritis\nnodosa with persistently high HBV DNA level, cir\nrhosis regardless of HBV DNA level\n\u0002 HBEAG NEGATIVE PATIENTS (PRE-CORE OR CORE PRO-\nMOTER MUTATIONS)\nhigh HBV DNA level\nPlease see NEJM 2008 359:14 and Can J Gastro\nenterol 2007 21 Supp C at www.hepatology.ca\nfor consensus statement on management of hepati\ntis B\nHepatitis C\nNEJM 2001 345:1\nPATHOPHYSIOLOGY\nNATURAL HISTORY\nacute infection ! 55 85% of\ntotal will develop chronic infection ! 50% of total\nwill develop chronic hepatitis ! 5 20% of total will\ndevelop cirrhosis ! 3 5%/year of acute decompen\nsation, also 1 5%/year of developing hepatocellular\ncarcinoma (after 10 30 years)\nRISK FACTORS FOR TRANSMISSION\n\u0002\nHIGH\nIDU, transfusions, immigration from ende\nmic regions\n\u0002\nLOW\nperinatal transmission, transfusion before\n1992, body piercing, long term dialysis, occupa\ntional exposure, intranasal drug use, multiple sex\nual partners\nCLINICAL FEATURES\nHISTORY\nsymptoms of liver failure (jaundice, bleed\ning, infections, ascites, confusion), weight change, risk\nfactors of hepatitis (sexual activity, IDU, tattoos, pier\ncing, healthcare worker, transfusions, dialysis), past\nmedical history (alcohol, HBV, HIV), medication history\nPHYSICAL\nliver examination, stigmata of chronic\nliver disease (see p. 132), weight. Also examine for\nextrahepatic manifestations of HCV\nRelated Topics\nAcute Liver Failure (p. 128)\nChronic Liver Failure (p. 132)\nHCV/HIV Co infection (p. 261)\nHepatitis B (p. 130)\nHepatoma (p. 205)\nHBsAg\nHBclgM\nHBsAb\nHBclgG\nHBeAg\nHBeAb\nAcute infection\nEarly\n+\n+\nWindow\n+\n+\nLate\n+/\n+\n+\nImmunity\nVaccinated\n+\nCured\n+/\n+\n+\nChronic infection\nInfectious/active\n+\n+\n+\nPre core mutant\n+\n+\nLow replicative\n+\n+\n+\nHepatitis C\n131", "text_length": 2835, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 143/464)", "type": "chunk", "chunk_index": 142, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.442726", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.443478", "status": "complete", "chunks_added": 2}